Pathogens Identified in Patients with Ventilator Associated Pneumonia and their Impact on Outcomes
Background: Ventilator-associated pneumonia (VAP) is associated with prolonged hospitalisation, excessive antibiotic use and high mortality. The role of the various pathogens identified in patients with VAP is not well known especially in low and middle income countries (LMIC) and high income countr...
Main Authors: | Dr Srishti Chhabra, Dr. Suchart Booraphun, Dr. Andrew Yunkai Li, Dr. Pornanan Domthong, Dr. Gyan Kayastha, Dr. Yie Hui Lau, Dr. Ploenchan Chetchotisakd, Professor Direk Limmathurotsakul, Professor Paul Anantharajah Tambyah, Professor Ben S Cooper, Dr. Yin Mo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971224007604 |
Similar Items
-
Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial
by: Yin Mo, et al.
Published: (2021-05-01) -
Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial
by: Mo, Y, et al.
Published: (2024) -
Rapid onset of bronchiectasis in COVID-19 Pneumonia: two cases studied with CT
by: Maria Chiara Ambrosetti, Dr, et al.
Published: (2020-11-01) -
Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial
by: Mo, Y, et al.
Published: (2021) -
Purulent Streptococcus pneumoniae meningoencephalitis in adults in Casablanca
by: Dr Hassan Kamena Mwana-yile Mwana-yile, et al.
Published: (2025-03-01)